Table 1.
Nanoparticle | Hydrodynamic size (nm) |
PDI | Zeta potential (mV) |
Loading capacity (μg/mg NPs) |
Encapsulation efficiency (%) |
OVA content (μg/mg NPs) |
---|---|---|---|---|---|---|
Empty NP | 231.2 ± 2.17 | 0.096 | −42.55 ± 2.99 | NA | NA | NA |
NPOVA | 246.5 ± 3.01 | 0.105 | −44.37 ± 2.81 | NA | NA | 51.61 ± 2.32 |
NPApoBP | 250.9 ± 3.81 | 0.112 | −11.44 ± 4.02 | 11.65 ± 0.75 (ApoBP ligand) |
5.1 (mol% of PLGA) |
NA |
NPOVA/ApoBP | 270.8 ± 4.96 | 0.113 | −4.56 ± 2.25 | 12.96 ± 0.77 (ApoBP ligand) |
5.3 (mol% of PLGA) |
50.12 ± 2.18 |
NPCurcumin | 251.2 ± 3.27 | 0.108 | −35.77 ± 3.52 | 66.12 ± 3.70 | 38.94 ± 2.14 | NA |
NPOVA-Curcumin | 255.7 ± 4.44 | 0.129 | −38.42 ± 2.95 | 64.52 ± 2.69 | 37.06 ± 3.62 | 50.66 ± 2.68 |
NPRapa | 246.3 ± 5.47 | 0.120 | −36.28 ± 3.41 | 23.44 ± 3.56 | 33.66 ± 5.24 | NA |
NPOVA-Rapa | 252.5 ± 3.88 | 0.139 | −39.38 ± 2.99 | 22.31 ± 6.58 | 31.77 ± 3.94 | 46.88 ± 2.76 |